Fall Xconomy Xchange to Focus on Reinventing Biotech for the Big Apple

New York City has everything to offer to anyone interested in working in biotech, from top-notch science programs at colleges like Columbia and NYU, to access to top venture capitalists. So why do so many biotech entrepreneurs leave New York? Many fear there’s not enough affordable wet-lab space, or they can’t attract enough scientific talent because young folks think it’s too expensive to live in the city.

On October 4, Xconomy will convene the best biotech minds in NYC for a discussion about what can be done to build a thriving biotech cluster in New York. We’re calling it “Reinventing Biotech’s Business Model for the Big Apple.” We’ll hear from entrepreneurs, venture capitalists, and other experts who have succeeded at growing biotech startups in New York—or helped entrepreneurs to do so.

The evening will kick off with a keynote speech from Sam Waksal, founder and CEO of Kadmon Pharmaceuticals. Waksal will share what he’s learned about entrepreneurship in NYC, not only from Kadmon but also from his earlier experience founding ImClone Systems.

Then a top-notch group of panelists will discuss their ideas for tailoring the traditional business model to New York City. They’ll cover such topics as pros and cons of the virtual business model, tips for raising funds from non-profit organizations, and the outlook for venture capital funding in biotech.

Panelists include:

Dennis Purcell, Senior Managing Partner, Aisling Capital (Moderator)

Jill O’Donnell-Tormey, CEO and Director of Scientific Affairs, Cancer Research Institute

Kevin Kinsella, Founder, Managing Director, Avalon Ventures

Arthur Tinklelenberg, CEO, Enumeral Biomedical

All the participants except Kinsella are based in the New York area. The veteran VC will be flying in from San Diego, which he helped establish as a biotech hub, but as the son of former Broadway and television actor Walter Kinsella, and the largest individual producer of Jersey Boys, he knows New York well.

Our Xconomy Xchange: Reinventing Biotech for the Big Apple will take place at the Apella Event Space at Alexandria Center for Life Science, and it will include a reception and plenty of time for networking.

You can find more information—plus special discounted ticket prices for early birds, students, and startups—by clicking here. Please join Xconomy for this important discussion.

Author: Arlene Weintraub

Arlene is an award-winning journalist specializing in life sciences and technology. She was previously a senior health writer based out of the New York City headquarters of BusinessWeek, where she wrote hundreds of articles that explored both the science and business of health. Her freelance pieces have been published in USA Today, US News & World Report, Technology Review, and other media outlets. Arlene has won awards from the New York Press Club, the Association of Health Care Journalists, the Foundation for Biomedical Research, and the American Society of Business Publication Editors. Her book about the anti-aging industry, Selling the Fountain of Youth, was published by Basic Books in September 2010.